<DOC>
	<DOCNO>NCT02193594</DOCNO>
	<brief_summary>Preoperative chemoradiotherapy ( CRT ) introduce comprehensive treatment gastroesophageal junction upper gastric cancer decade.According research , CRT show good curative effect local control prolong overall survival.However , optimization scheme CRT influence surgery remain controversial.Meanwhile , many design flaw past research , lack adjuvant chemotherapy , insufficiency lymphnodes dissection.We decide carry trial , eliminate bias far , illustrate efficacy safety CRT .</brief_summary>
	<brief_title>Preoperative Concurrent Chemoradiotherapy Locally Advanced Gastroesophageal Junction Upper Gastric Adenocarcinoma</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Histologically proven adenocarcinoma gastroesophageal junction . Clinical stage diagnose endoscopic ultrasound ( EUS ) compute tomography ( CT ) T34NxM0 tumor , accord American Joint Committee Cancer ( AJCC ) 7th edition . Eastern Cooperative Oncology Group ( ECOG ) performance status≤2 . Informed consent obtain . Combined malignant tumor . Eastern Cooperative Oncology Group ( ECOG ) performance status＞2 . Combined severe organ dysfunction . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Preoperative concurrent chemoradiotherapy</keyword>
	<keyword>Neoadjuvant chemoradiotherapy</keyword>
	<keyword>Gastroesophageal junction adenocarcinoma</keyword>
</DOC>